Medline Reports Third-Quarter Sales of $7.86 Billion

Medline reported third-quarter 2026 net sales of $7.856 billion, up 10.4% year over year, while net income declined 1.2% to $318 million. Adjusted EBITDA increased 11.8% to $960 million, and Adjusted Diluted EPS was $0.44. The company raised its full-year Organic Sales growth outlook and reaffirmed…